HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 13.43
+0.57 (4.43%)
May 7, 2026, 4:08 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 11.22 billion as of May 7, 2026. Its market cap has increased by 115.94% in one year.
Market Cap
11.22B
Enterprise Value
8.72B
Revenue
1.23B
Ranking
n/a
PE Ratio
15.69
Stock Price
13.43
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 11.22B, an increase of 32.61%. That is a compound annual growth rate of 5.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 10.75B | 5.70% |
| Dec 31, 2025 | 10.17B | 646.15% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Leads Biolabs | 15.67B |
| Ascentage Pharma Group International | 15.55B |
| CStone Pharmaceuticals | 13.70B |
| Everest Medicines | 11.86B |
| CARsgen Therapeutics Holdings | 11.84B |
| Alphamab Oncology | 9.71B |
| Shanghai Haohai Biological Technology | 9.32B |
| Lepu Biopharma | 9.27B |